Role of MHC Class I Pathways in Antigen Presentation

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2023 Apr 3

PMID 37009503

Authors

Karolina D Witt

Affiliations

Soon will be listed here.

Abstract

MHC class I antigen processing is an underappreciated area of nonviral host-pathogen interactions, bridging both immunology and cell biology, where the pathogen's natural life cycle involves little presence in the cytoplasm. The effective response to MHC-I foreign antigen presentation is not only cell death but also phenotypic changes in other cells and stimulation of the memory cells ready for the next antigen reoccurrence. This review looks at the MHC-I antigen processing pathway and potential alternative sources of the antigens, focusing on () as an intracellular pathogen that co-evolved with humans and developed an array of decoy strategies to survive in a hostile environment by manipulating host immunity to its own advantage. As that happens the selective antigen presentation process, reinforcement of the effective antigen recognition on MHC-I molecules may stimulate subsets of effector cells that act earlier and more locally. Vaccines against tuberculosis (TB) could potentially eliminate this disease, yet their development has been slow, and success is limited in the context of this global disease's spread. This review's conclusions set out potential directions for MHC-I-focused approaches for the next generation of vaccines.

Citing Articles

RNA vaccines: The dawn of a new age for tuberculosis?.

Li J, Liu D, Li X, Wei J, Du W, Zhao A Hum Vaccin Immunother. 2025; 21(1):2469333.

PMID: 40013818 PMC: 11869779. DOI: 10.1080/21645515.2025.2469333.

Intracellular Pathogens: Infection, Immunity, and Intervention.

Martens-Koop A, Thakur A Methods Mol Biol. 2024; 2813:1-17.

PMID: 38888767 DOI: 10.1007/978-1-0716-3890-3_1.

References

Lella R, Sharma C . Eis (enhanced intracellular survival) protein of Mycobacterium tuberculosis disturbs the cross regulation of T-cells. J Biol Chem. 2007; 282(26):18671-5. DOI: 10.1074/jbc.C600280200. View

Kim K, An D, Song J, Yoon J, Kim H, Yoon H . Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A. 2012; 109(20):7729-34. PMC: 3356628. DOI: 10.1073/pnas.1120251109. View

Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Eddine A . Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. J Clin Invest. 2005; 115(9):2472-9. PMC: 1187936. DOI: 10.1172/JCI24617. View

Chen M, Divangahi M, Gan H, Shin D, Hong S, Lee D . Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med. 2008; 205(12):2791-801. PMC: 2585850. DOI: 10.1084/jem.20080767. View

Gan H, Lee J, Ren F, Chen M, Kornfeld H, Remold H . Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence. Nat Immunol. 2008; 9(10):1189-97. PMC: 5351782. DOI: 10.1038/ni.1654. View

Trost B, Lucchese G, Stufano A, Bickis M, Kusalik A, Kanduc D . No human protein is exempt from bacterial motifs, not even one. Self Nonself. 2011; 1(4):328-334. PMC: 3062388. DOI: 10.4161/self.1.4.13315. View

Ndiaye B, Thienemann F, Ota M, Landry B, Camara M, Dieye S . Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2015; 3(3):190-200. PMC: 4648060. DOI: 10.1016/S2213-2600(15)00037-5. View

Bettencourt P, Muller J, Nicastri A, Cantillon D, Madhavan M, Charles P . Identification of antigens presented by MHC for vaccines against tuberculosis. NPJ Vaccines. 2020; 5(1):2. PMC: 6941960. DOI: 10.1038/s41541-019-0148-y. View

Tantivitayakul P, Juthayothin T, Ruangchai W, Smittipat N, Disratthakit A, Mahasirimongkol S . Identification and functional prediction of lineage-specific SNPs distributed in DosR-related proteins and resuscitation-promoting factor proteins of . Heliyon. 2020; 6(12):e05744. PMC: 7753917. DOI: 10.1016/j.heliyon.2020.e05744. View

10.

Kimmey J, Stallings C . Bacterial Pathogens versus Autophagy: Implications for Therapeutic Interventions. Trends Mol Med. 2016; 22(12):1060-1076. PMC: 5215815. DOI: 10.1016/j.molmed.2016.10.008. View

11.

Rodo M, Rozot V, Nemes E, Dintwe O, Hatherill M, Little F . A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates. PLoS Pathog. 2019; 15(3):e1007643. PMC: 6417742. DOI: 10.1371/journal.ppat.1007643. View

12.

Chen J, Zhang M, Rybniker J, Boy-Rottger S, Dhar N, Pojer F . Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence. Mol Microbiol. 2013; 89(6):1154-66. DOI: 10.1111/mmi.12336. View

13.

Vico T, Youssif C, Zare F, Comalada M, Sebastian C, Lloberas J . GM-CSF Protects Macrophages from DNA Damage by Inducing Differentiation. Cells. 2022; 11(6). PMC: 8946476. DOI: 10.3390/cells11060935. View

14.

Amaral E, Costa D, Namasivayam S, Riteau N, Kamenyeva O, Mittereder L . A major role for ferroptosis in -induced cell death and tissue necrosis. J Exp Med. 2019; 216(3):556-570. PMC: 6400546. DOI: 10.1084/jem.20181776. View

15.

Sperisen P, Schmid C, Bucher P, Zilian O . Stealth proteins: in silico identification of a novel protein family rendering bacterial pathogens invisible to host immune defense. PLoS Comput Biol. 2005; 1(6):e63. PMC: 1285062. DOI: 10.1371/journal.pcbi.0010063. View

16.

Germain R . MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 1994; 76(2):287-99. DOI: 10.1016/0092-8674(94)90336-0. View

17.

Leddon S, Sant A . Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules. Curr Opin Organ Transplant. 2010; 15(4):505-11. PMC: 3085167. DOI: 10.1097/MOT.0b013e32833bfc5c. View

18.

Teitelbaum R, Cammer M, Maitland M, Freitag N, Condeelis J, Bloom B . Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc Natl Acad Sci U S A. 1999; 96(26):15190-5. PMC: 24795. DOI: 10.1073/pnas.96.26.15190. View

19.

Hossain M, Norazmi M . Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword?. Biomed Res Int. 2013; 2013:179174. PMC: 3844256. DOI: 10.1155/2013/179174. View

20.

Gardiner G, Deffit S, McLetchie S, Perez L, Walline C, Blum J . A role for NADPH oxidase in antigen presentation. Front Immunol. 2013; 4:295. PMC: 3779930. DOI: 10.3389/fimmu.2013.00295. View